Compare Entegris Inc (ENTG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs Tenet Healthcare Corporation — how do they compare? Entegris Inc trades at $154 (market cap $23.24B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Entegris Inc and Tenet Healthcare Corporation are close in size by market cap, and Entegris Inc pays a 0.26% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| ENTG | THC | |
|---|---|---|
Market Cap | $23.24B | $20.93B |
Sector | Technology | Health |
52-Week High | $184.00 | $262.63 |
52-Week Low | $68.80 | $161.37 |
Enterprise Value | $26.44B | $32.01B |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENTG is trading at $152.08, up 6.61% over 24 hours, near its consensus price target of $181.17. The stock shows bullish momentum with strong earnings beats in recent quarters, driven by AI-related semiconductor demand. Technical indicators suggest a bullish trend, though RSI hints at overbought conditions. Revenue growth and margin expansion are supported by increasing chip complexity and purity solutions demand.
Outlook remains positive with analyst consensus favoring Buy (66.67%), but high valuation multiples like P/E of 76.04 pose risks. Key opportunities include sustained AI-driven growth, while risks involve valuation sensitivity and semiconductor cycle volatility. The company's cash flow stability and strategic positioning in advanced segments support long-term potential.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
